- Home
- FMST vs TLPH Comparison
FMST vs TLPH Comparison
Compare FMST & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- TLPH
- Stock Information
- Founded
- FMST 2005
- TLPH 2005
- Country
- FMST Canada
- TLPH United States
- Employees
- FMST N/A
- TLPH N/A
- Industry
- FMST Other Metals and Minerals
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- TLPH Health Care
- Exchange
- FMST Nasdaq
- TLPH Nasdaq
- Market Cap
- FMST 15.8M
- TLPH 13.4M
- IPO Year
- FMST N/A
- TLPH 2011
- Fundamental
- Price
- FMST $2.00
- TLPH $0.73
- Analyst Decision
- FMST
- TLPH Strong Buy
- Analyst Count
- FMST 0
- TLPH 2
- Target Price
- FMST N/A
- TLPH $4.50
- AVG Volume (30 Days)
- FMST 13.3K
- TLPH 130.8K
- Earning Date
- FMST 01-01-0001
- TLPH 11-13-2024
- Dividend Yield
- FMST N/A
- TLPH N/A
- EPS Growth
- FMST N/A
- TLPH N/A
- EPS
- FMST N/A
- TLPH N/A
- Revenue
- FMST N/A
- TLPH $398,000.00
- Revenue This Year
- FMST N/A
- TLPH N/A
- Revenue Next Year
- FMST N/A
- TLPH N/A
- P/E Ratio
- FMST N/A
- TLPH N/A
- Revenue Growth
- FMST N/A
- TLPH 57.31
- 52 Week Low
- FMST $1.94
- TLPH $0.46
- 52 Week High
- FMST $4.25
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- FMST 33.44
- TLPH 35.69
- Support Level
- FMST $1.94
- TLPH $0.65
- Resistance Level
- FMST $2.19
- TLPH $0.93
- Average True Range (ATR)
- FMST 0.19
- TLPH 0.08
- MACD
- FMST -0.01
- TLPH -0.03
- Stochastic Oscillator
- FMST 8.43
- TLPH 18.69
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.